The InWave medical device will be manufactured, marketed and sold through the company’s Zynex Medical subsidiary.
“We are very excited about the introduction of this new product,” said Thomas Sandgaard, CEO of Zynex, in the release. “The InWave adds to our already broad product line and is reimbursed by health insurance. We believe it will provide our expanding sales force an additional tool to fuel revenue generation in our rapid growing Zynex Medical subsidiary.”
Zynex is headquartered in Lone Tree, Colo.
Related Articles on FDA Clearances:
AngioDynamics receives FDA Clearance for Peripherally Inserted Central Catheter
Symmetry Medical Receives FDA Clearance for FLASH PAK Evolution Valve
Covidien Receives FDA Clearance for Stapling System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
